Neoadjuvant Chemotherapy

Pipeline Programs↗

Active Trials↗

Companies Involved↗

Neoadjuvant Chemotherapy is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

41/100

Pipeline Velocity

27/100

Mech. Concentration

N/A

Completion Rate

77/100

Attrition Rate

7/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

clinical trials

Completed20 · 27%

Unknown status18 · 24%

Recruiting17 · 23%

Not yet recruiting10 · 13%

Terminated4 · 5%

Active, not recruiting3 · 4%

Other3 · 4%

Clinical Trials

Trial Activity

75 trials

Planed Organ Preservation for Low Rectal Cancer After Neoadjuvant Chemotherapy (OPLAR)

Recruiting·WWest China Hospital·Phase 3·NCT07070622·186 enrolled

Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy

Recruiting·UUniversity Hospital, Rouen·Phase 3·NCT06107920·232 enrolled

Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer

Recruiting·National Cancer Institute (NCI)·Phase 2·NCT06223568·70 enrolled

Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer.

Recruiting·—·Phase 2·NCT04277858·60 enrolled

Camrelizumab Plus Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Chemoradiotherapy in Resectable ESCC.

Recruiting·—·Phase 3·NCT05043688·426 enrolled

Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Sarcomas (TORNADO)

Recruiting·IInstitut Bergonié·Phase 2·NCT04968106·66 enrolled

Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPC

Recruiting·SSahlgrenska University Hospital·Phase 3·NCT06714604·432 enrolled

PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples

Recruiting·MMedical College of Wisconsin·Phase 2·NCT04683315·84 enrolled

Narlumosbartmab Combined With Neoadjuvant Chemotherapy in Bone-derived Malignancies With Osteolytic Lesions and Multinucleated Giant Cells

Recruiting·PPeking University People's Hospital·N/A·NCT06302465·60 enrolled

Effect of Neoadjuvant Chemotherapy on MRI Accuracy Before Cystectomy

Recruiting·—·N/A·NCT07202819·76 enrolled

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

Recruiting·CCanadian Cancer Trials Group·Phase 3·NCT06205485·250 enrolled

Neoadjuvant Chemotherapy Combined With Sintilimab and Bevacizumab for TNBC (NEOTORCH-BREAST07)

Recruiting·FFirst Affiliated Hospital of Zhejiang University·Phase 2·NCT07351487·37 enrolled

Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002)

Recruiting·TTianjin Medical University Cancer Institute and Hospital·Phase 3·NCT04807673·342 enrolled

Primary Chemoradiation VS. Neoadjuvant Chemotherapy Followed By Surgery As Treatment Strategy For LAVC

Recruiting·TThe Netherlands Cancer Institute·Phase 2·NCT05905315·98 enrolled

Camrelizumab Combined With Neoadjuvant Chemotherapy After Stent Placement for Left-Sided Obstructive Colonic Cancer

Recruiting·—·N/A·NCT05202314·20 enrolled

Page 1 of 5

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)